-
1
-
-
84859945784
-
Analysis of pathogen and host factors related to clinical outcomes in patients with hospital-acquired pneumonia dueto methicillin-resistant Staphylococcus aureus.
-
Haque NZ, Arshad S, Peyrani P et al. Analysis of pathogen and host factors related to clinical outcomes in patients with hospital-acquired pneumonia dueto methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2012;50: 1640-4.
-
(2012)
J Clin Microbiol
, vol.50
, pp. 1640-1644
-
-
Haque, N.Z.1
Arshad, S.2
Peyrani, P.3
-
2
-
-
80052262626
-
Increased mortality associated with methicillin-resistant Staphylococcus aureus (MRSA) infection in the intensive care unit: results from the EPIC II study
-
Hanberger H, Walther S, Leone M et al. Increased mortality associated with methicillin-resistant Staphylococcus aureus (MRSA) infection in the intensive care unit: results from the EPIC II study. Int J Antimicrob Agents 2011; 38: 331-5.
-
(2011)
Int J Antimicrob Agents
, vol.38
, pp. 331-335
-
-
Hanberger, H.1
Walther, S.2
Leone, M.3
-
3
-
-
67651083250
-
Vancomycin therapeutic guidelines: a summary of consensus recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists
-
Rybak MJ, Lomaestro BM, Rotschafer JC et al. Vancomycin therapeutic guidelines: a summary of consensus recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists. Clin Infect Dis 2009; 49: 325-37.
-
(2009)
Clin Infect Dis
, vol.49
, pp. 325-337
-
-
Rybak, M.J.1
Lomaestro, B.M.2
Rotschafer, J.C.3
-
4
-
-
84857611419
-
The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis
-
van Hal SJ, Lodise TP, Paterson DL. The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis. Clin Infect Dis 2012; 54: 755-71.
-
(2012)
Clin Infect Dis
, vol.54
, pp. 755-771
-
-
van Hal, S.J.1
Lodise, T.P.2
Paterson, D.L.3
-
5
-
-
70349085778
-
Pharmacodynamics of vancomycin at simulated epithelial lining fluid concentrations against methicillinresistant Staphylococcus aureus (MRSA): implications for dosing in MRSA pneumonia
-
Harigaya Y, Bulitta JB, Forrest A et al. Pharmacodynamics of vancomycin at simulated epithelial lining fluid concentrations against methicillinresistant Staphylococcus aureus (MRSA): implications for dosing in MRSA pneumonia. Antimicrob Agents Chemother 2009; 53: 3894-901.
-
(2009)
Antimicrob Agents Chemother
, vol.53
, pp. 3894-3901
-
-
Harigaya, Y.1
Bulitta, J.B.2
Forrest, A.3
-
6
-
-
44249096170
-
Therapeutic drug monitoring of vancomycin in severe sepsis and septic shock
-
Vázquez M, Fagiolino P, Boronat A et al. Therapeutic drug monitoring of vancomycin in severe sepsis and septic shock. Int J Clin Pharmacol Ther 2008; 46: 140-5.
-
(2008)
Int J Clin Pharmacol Ther
, vol.46
, pp. 140-145
-
-
Vázquez, M.1
Fagiolino, P.2
Boronat, A.3
-
7
-
-
62849095029
-
Pharmacokinetic issues for antibiotics in the critically ill patient
-
Roberts JA, Lipman J. Pharmacokinetic issues for antibiotics in the critically ill patient. Crit Care Med 2009; 37: 840-51.
-
(2009)
Crit Care Med
, vol.37
, pp. 840-851
-
-
Roberts, J.A.1
Lipman, J.2
-
8
-
-
84859420783
-
Augmentedrenal clearance in septic patients and implications for vancomycin optimisation
-
Baptista JP, Sousa E, Martins PJ. et al. Augmentedrenal clearance in septic patients and implications for vancomycin optimisation. Int J Antimicrob Agents 2012; 39: 420-3.
-
(2012)
Int J Antimicrob Agents
, vol.39
, pp. 420-423
-
-
Baptista, J.P.1
Sousa, E.2
Martins, P.J.3
-
9
-
-
84858285471
-
Determinants of early inadequate vancomycin concentrations during continuous infusion in septic patients
-
Ocampos-Martinez E, Penaccini L, Scolletta S et al. Determinants of early inadequate vancomycin concentrations during continuous infusion in septic patients. Int J Antimicrob Agents 2012; 39: 332-7.
-
(2012)
Int J Antimicrob Agents
, vol.39
, pp. 332-337
-
-
Ocampos-Martinez, E.1
Penaccini, L.2
Scolletta, S.3
-
10
-
-
0034863918
-
Continuous renal replacement therapy in critically ill patients
-
Ronco C, Bellomo R, Ricci Z. Continuous renal replacement therapy in critically ill patients. Nephrol Dial Transplant 2001; 16: 67-72.
-
(2001)
Nephrol Dial Transplant
, vol.16
, pp. 67-72
-
-
Ronco, C.1
Bellomo, R.2
Ricci, Z.3
-
11
-
-
36248946604
-
Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy
-
Pea F, Viale P, Pavan F. et al. Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy. Clin Pharmacokinet 2007; 46: 997-1038.
-
(2007)
Clin Pharmacokinet
, vol.46
, pp. 997-1038
-
-
Pea, F.1
Viale, P.2
Pavan, F.3
-
12
-
-
79955772659
-
Antibiotic dosing in multiple organ dysfunction syndrome
-
Ulldemolins M, Roberts JA, Lipman J. et al. Antibiotic dosing in multiple organ dysfunction syndrome. Chest 2011; 139: 1210-20.
-
(2011)
Chest
, vol.139
, pp. 1210-1220
-
-
Ulldemolins, M.1
Roberts, J.A.2
Lipman, J.3
-
13
-
-
84861489948
-
Vancomycin concentrations are frequently subtherapeutic during continuous venovenous hemodialysis (CVVHD)
-
Wilson FP, Berns JS. Vancomycin concentrations are frequently subtherapeutic during continuous venovenous hemodialysis (CVVHD). Clin Nephrol 2012; 77: 329-31.
-
(2012)
Clin Nephrol
, vol.77
, pp. 329-331
-
-
Wilson, F.P.1
Berns, J.S.2
-
14
-
-
4444251438
-
Vancomycin pharmacokinetics in critically ill patients receiving continuous venovenous haemodiafiltration
-
DelDot ME, Lipman J, Tett SE. Vancomycin pharmacokinetics in critically ill patients receiving continuous venovenous haemodiafiltration. Br J Clin Pharmacol 2004; 58: 259-68.
-
(2004)
Br J Clin Pharmacol
, vol.58
, pp. 259-268
-
-
DelDot, M.E.1
Lipman, J.2
Tett, S.E.3
-
15
-
-
79959732600
-
Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients
-
Chaijamorn W, Jitsurong A, Wiwattanawongsa K. et al. Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients. Int J Antimicrob Agents 2011; 38: 152-6.
-
(2011)
Int J Antimicrob Agents
, vol.38
, pp. 152-156
-
-
Chaijamorn, W.1
Jitsurong, A.2
Wiwattanawongsa, K.3
-
16
-
-
0032694744
-
Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients
-
Boereboom FT, Ververs FF, Blankestijn PJ. et al. Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients. Intensive Care Med 1999; 25: 1100-4.
-
(1999)
Intensive Care Med
, vol.25
, pp. 1100-1104
-
-
Boereboom, F.T.1
Ververs, F.F.2
Blankestijn, P.J.3
-
17
-
-
0031749303
-
Determinants of vancomycin clearance by continuous venovenous hemofiltration and continuous venovenous hemodialysis
-
Joy MS, Matzke GR, Frye RF. et al. Determinants of vancomycin clearance by continuous venovenous hemofiltration and continuous venovenous hemodialysis. Am J Kidney Dis 1998; 31: 1019-27.
-
(1998)
Am J Kidney Dis
, vol.31
, pp. 1019-1027
-
-
Joy, M.S.1
Matzke, G.R.2
Frye, R.F.3
-
18
-
-
17944367778
-
Continuous versus intermittent infusion of vancomycin in severe staphylococcal infections: prospective multicenter randomized study
-
Wysocki M, Delatour F, Faurisson F. et al. Continuous versus intermittent infusion of vancomycin in severe staphylococcal infections: prospective multicenter randomized study. Antimicrob Agents Chemother 2001, 45: 2460-7.
-
(2001)
Antimicrob Agents Chemother
, vol.45
, pp. 2460-2467
-
-
Wysocki, M.1
Delatour, F.2
Faurisson, F.3
-
19
-
-
84859170733
-
Continuous versus intermittent infusion of vancomycin for the treatment of Gram-positive infections: systematic review and meta-analysis
-
Cataldo MA, Tacconelli E, Grilli E. et al. Continuous versus intermittent infusion of vancomycin for the treatment of Gram-positive infections: systematic review and meta-analysis. J Antimicrob Chemother 2012; 67: 17-24.
-
(2012)
J Antimicrob Chemother
, vol.67
, pp. 17-24
-
-
Cataldo, M.A.1
Tacconelli, E.2
Grilli, E.3
-
20
-
-
84864237868
-
Continuous infusion of antibiotics in the critically ill: the new holy grail for b-lactams and vancomycin?
-
Van Herendael B, Jeurissen A, Tulkens PM. et al. Continuous infusion of antibiotics in the critically ill: the new holy grail for b-lactams and vancomycin? Ann Intensive Care 2012; 2: 22.
-
(2012)
Ann Intensive Care
, vol.2
, pp. 22
-
-
Van Herendael, B.1
Jeurissen, A.2
Tulkens, P.M.3
-
21
-
-
84872901678
-
Continuous infusion of vancomycin in septic patients on continuous renal replacement therapy
-
Covajes C, Scoletta S, Penaccini L. et al. Continuous infusion of vancomycin in septic patients on continuous renal replacement therapy. Int J Antimicrob Agents, 2013; 41: 262-6.
-
(2013)
Int J Antimicrob Agents
, vol.41
, pp. 262-266
-
-
Covajes, C.1
Scoletta, S.2
Penaccini, L.3
-
22
-
-
79956324640
-
Vancomycin dosing in critically ill patients: robust methods for improved continuous-infusion regimens
-
Roberts JA, Taccone FS, Udy AA. et al. Vancomycin dosing in critically ill patients: robust methods for improved continuous-infusion regimens. Antimicrob Agents Chemother 2011; 55: 2704-9.
-
(2011)
Antimicrob Agents Chemother
, vol.55
, pp. 2704-2709
-
-
Roberts, J.A.1
Taccone, F.S.2
Udy, A.A.3
-
23
-
-
0022256529
-
APACHE II: a severity of disease classification system
-
KnausWA, Draper EA,Wagner DP. et al. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13: 818-29.
-
(1985)
Crit Care Med
, vol.13
, pp. 818-829
-
-
Knaus, W.A.1
Draper, E.A.2
Wagner, D.P.3
-
24
-
-
0030015661
-
The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine
-
Vincent JL, Moreno R, Takala J. et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996; 22: 707-10.
-
(1996)
Intensive Care Med
, vol.22
, pp. 707-710
-
-
Vincent, J.L.1
Moreno, R.2
Takala, J.3
-
26
-
-
0033120135
-
A procedure for generating bootstrap samples for the validation of nonlinear mixed-effects population models
-
Parke J, Holford NH, Charles BG. A procedure for generating bootstrap samples for the validation of nonlinear mixed-effects population models. Comput Methods Programs Biomed 1999; 59: 119-29.
-
(1999)
Comput Methods Programs Biomed
, vol.59
, pp. 119-129
-
-
Parke, J.1
Holford, N.H.2
Charles, B.G.3
-
27
-
-
0029397906
-
Antimicrobial prescribing in patients on haemofiltration
-
Cotterill S. Antimicrobial prescribing in patients on haemofiltration. J Antimicrob Chemother 1995; 36: 773-80.
-
(1995)
J Antimicrob Chemother
, vol.36
, pp. 773-780
-
-
Cotterill, S.1
-
28
-
-
84055213987
-
Initial vancomycin dosing recommendations for critically ill patients undergoing continuous venovenous hemodialysis
-
van de Vijsel LM, Walker SA, Walker SE. et al. Initial vancomycin dosing recommendations for critically ill patients undergoing continuous venovenous hemodialysis. Can J Hosp Pharm 2010; 63: 196-206.
-
(2010)
Can J Hosp Pharm
, vol.63
, pp. 196-206
-
-
van de Vijsel, L.M.1
Walker, S.A.2
Walker, S.E.3
-
30
-
-
84861549960
-
Elimination of teicoplanin by adsorption to the filter membrane during haemodiafiltration: screening experiments for linezolid, teicoplanin and vancomycin followed by in vitro haemodiafiltration models for teicoplanin
-
Shiraishi Y, Okajima M, Sai Y. et al. Elimination of teicoplanin by adsorption to the filter membrane during haemodiafiltration: screening experiments for linezolid, teicoplanin and vancomycin followed by in vitro haemodiafiltration models for teicoplanin. Anaesth Intensive Care 2012; 40: 442-9.
-
(2012)
Anaesth Intensive Care
, vol.40
, pp. 442-449
-
-
Shiraishi, Y.1
Okajima, M.2
Sai, Y.3
-
31
-
-
70350619885
-
Correlation between free and total vancomycin serum concentrations in patients treated for Gram-positive infections
-
Berthoin K, Ampe E, Tulkens PM. et al. Correlation between free and total vancomycin serum concentrations in patients treated for Gram-positive infections. Int J Antimicrob Agents 2009; 34: 555-60.
-
(2009)
Int J Antimicrob Agents
, vol.34
, pp. 555-560
-
-
Berthoin, K.1
Ampe, E.2
Tulkens, P.M.3
-
32
-
-
79952105014
-
Longitudinal hemodiafilter performance in modeled continuous renal replacement therapy
-
Pasko DA, Churchwell MD, Salama NN. et al. Longitudinal hemodiafilter performance in modeled continuous renal replacement therapy. Blood Purif 2011; 32: 82-8.
-
(2011)
Blood Purif
, vol.32
, pp. 82-88
-
-
Pasko, D.A.1
Churchwell, M.D.2
Salama, N.N.3
-
33
-
-
34147129239
-
Ultrafiltration rate as a dose surrogate in pre-dilution hemofiltration
-
Huang Z, Letteri JJ, Clark WR et al. Ultrafiltration rate as a dose surrogate in pre-dilution hemofiltration. Int J Artif Organs 2007; 30: 124-32.
-
(2007)
Int J Artif Organs
, vol.30
, pp. 124-132
-
-
Huang, Z.1
Letteri, J.J.2
Clark, W.R.3
-
35
-
-
0027243672
-
Drug dosage in patients during continuous renal replacement therapy: pharmacokinetic and therapeutic considerations
-
Reetze-Bonorden P, Bohler J, Keller E. Drug dosage in patients during continuous renal replacement therapy: pharmacokinetic and therapeutic considerations. Clin Pharmacokinet 1993; 24: 362-79.
-
(1993)
Clin Pharmacokinet
, vol.24
, pp. 362-379
-
-
Reetze-Bonorden, P.1
Bohler, J.2
Keller, E.3
-
36
-
-
0035654136
-
Elimination of the piperacillin/ tazobactam combination during continuous venovenous haemofiltration and haemodiafiltration in patients with acute renal failure
-
Valtonen M, Tiula E, Takkunen O et al. Elimination of the piperacillin/ tazobactam combination during continuous venovenous haemofiltration and haemodiafiltration in patients with acute renal failure. J Antimicrob Chemother 2001; 48: 881-5.
-
(2001)
J Antimicrob Chemother
, vol.48
, pp. 881-885
-
-
Valtonen, M.1
Tiula, E.2
Takkunen, O.3
-
37
-
-
84860229974
-
Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: a multicentre pharmacokinetic study
-
Roberts DM, Roberts JA, Roberts MS et al. Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: a multicentre pharmacokinetic study. Crit Care Med 2012; 40: 1523-8.
-
(2012)
Crit Care Med
, vol.40
, pp. 1523-1528
-
-
Roberts, D.M.1
Roberts, J.A.2
Roberts, M.S.3
-
38
-
-
7444254040
-
Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratorytract infections
-
Moise-Broder PA, Forrest A, Birmingham MC et al. Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratorytract infections. ClinPharmacokinet2004;43:925-42.
-
(2004)
ClinPharmacokinet
, vol.43
, pp. 925-942
-
-
Moise-Broder, P.A.1
Forrest, A.2
Birmingham, M.C.3
-
39
-
-
84872925796
-
Vancomycin pharmacodynamics and survival in patients with methicillin-resistant Staphylococcus aureus-associated septic shock
-
Zelenitsky S, Rubinstein E, Ariano R et al. Vancomycin pharmacodynamics and survival in patients with methicillin-resistant Staphylococcus aureus-associated septic shock. Int J Antimicrob Agents 2013; 41: 255-60.
-
(2013)
Int J Antimicrob Agents
, vol.41
, pp. 255-260
-
-
Zelenitsky, S.1
Rubinstein, E.2
Ariano, R.3
|